1. Home
  2. XPON vs CMND Comparison

XPON vs CMND Comparison

Compare XPON & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

HOLD

Current Price

$1.11

Market Cap

6.2M

Sector

Technology

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$0.08

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPON
CMND
Founded
2016
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
XPON
CMND
Price
$1.11
$0.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2M
37.1M
Earning Date
11-13-2025
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,417,947.00
N/A
Revenue This Year
$61.26
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
109.37
N/A
52 Week Low
$0.60
$0.07
52 Week High
$5.50
$2.18

Technical Indicators

Market Signals
Indicator
XPON
CMND
Relative Strength Index (RSI) 43.74 16.25
Support Level $1.17 $0.07
Resistance Level $1.26 $0.13
Average True Range (ATR) 0.07 0.02
MACD 0.01 0.02
Stochastic Oscillator 38.64 8.87

Price Performance

Historical Comparison
XPON
CMND

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: